TissueMark software automatically marks and detects potentially cancerous sections in tissue samples with unprecedented levels of speed and accuracy... Find Out More
BELFAST, NORTHERN IRELAND, 2 January 2013: The seven-figure sum investment in medical technology company, PathXL, a Crescent Capital portfolio company, has been named... Find Out More
Digital pathology company to expand cancer research & diagnosis support products BELFAST, NORTHERN IRELAND, 13 December 2012: PathXL, a... Find Out More
PathXL Recognised for its Pioneering Digital Pathology Solutions LONDON, April 19, 2012 /PRNewswire/ — Based on its recent analysis of web-based software... Find Out More